Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Published:2010-11 Issue:11 Volume:20 Page:1209-1214
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kim Theo D.¹,Schwarz Michaela¹,Nogai Hendrik¹,Grille Peggy¹,Westermann Jörg¹,Plöckinger Ursula²,Braun Doreen³,Schweizer Ulrich³,Arnold Renate¹,Dörken Bernd¹,le Coutre Philipp¹

Affiliation:

1. Clinic for Hematology and Oncology, Charité—Universitätsmedizin Berlin, Berlin, Germany.

2. Interdisciplinary Metabolic Center and Charité—Universitätsmedizin Berlin, Berlin, Germany.

3. Institute for Expermental Endocrinology Charité—Universitätsmedizin Berlin, Berlin, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2010.0251

Reference34 articles.

1. How Does Sunitinib Cause Hypothyroidism?

2. Tyrosine kinase inhibitors and modifications of thyroid function tests: a review

3. Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy

4. Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

5. Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09

2. Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications;European Journal of Clinical Pharmacology;2024-03-14

3. The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review;International Journal of Clinical Pharmacy;2023-12-26

4. Tyrosine Kinase Inhibitors and Thyroid Toxicity;Biomedical and Pharmacology Journal;2023-09-30

5. Tyrosine kinase inhibitors induced thyroid dysfunction: myth or reality?;Reports of Practical Oncology and Radiotherapy;2023-08-28